Considerations for Managing Patients With Hematologic Malignancy During the COVID-19 Pandemic: The Seattle Strategy
| Autor: | Damian J. Green, Andrei R. Shustov, Chaitra S. Ujjani, Mary Elizabeth Percival, Andrew J. Cowan, Mazyar Shadman, Edward N. Libby, Stephen D. Smith, Ajay K. Gopal, Anna B. Halpern, Ryan C. Lynch, Bart L. Scott, Ryan D. Cassaday, Yolanda D. Tseng, Catherine Liu, Steven A. Pergam |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
Washington
medicine.medical_specialty Coronavirus disease 2019 (COVID-19) Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Pneumonia Viral MEDLINE Disease Medical Oncology Betacoronavirus 03 medical and health sciences 0302 clinical medicine Pandemic Humans Medicine 030212 general & internal medicine Disease management (health) Intensive care medicine Pandemics SARS-CoV-2 Oncology (nursing) business.industry Health Policy COVID-19 Disease Management Cancer medicine.disease Clinical trial Oncology Hematologic Neoplasms Care Delivery Reviews 030220 oncology & carcinogenesis Coronavirus Infections business |
| Zdroj: | JCO Oncol Pract |
| ISSN: | 2688-1535 2688-1527 |
| Popis: | In January 2020, the first documented patient in the United States infected with severe acute respiratory syndrome coronavirus 2 was diagnosed in Washington State. Since that time, community spread of coronavirus disease 2019 (COVID-19) in the state has changed the practice of oncologic care at our comprehensive cancer center in Seattle. At the Seattle Cancer Care Alliance, the primary oncology clinic for the University of Washington/Fred Hutchinson Cancer Consortium, our specialists who manage adult patients with hematologic malignancies have rapidly adjusted clinical practices to mitigate the potential risks of COVID-19 to our patients. We suggest that our general management decisions and modifications in Seattle are broadly applicable to patients with hematologic malignancies. Despite a rapidly changing environment that necessitates opinion-based care, we provide recommendations that are based on best available data from clinical trials and collective knowledge of disease states. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|